{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T01:52:15Z","timestamp":1781488335815,"version":"3.54.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010109","name":"Medizinische Universit\u00e4t Graz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020824","name":"Research Institute of Molecular Pathology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-026-01790-y","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:06:42Z","timestamp":1777432002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Monocytoid dendritic cells might be a specific marker for lung involvement in dermatomyositis"],"prefix":"10.1186","volume":"21","author":[{"given":"Johanna","family":"Knirsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Al-Effah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4970-1265","authenticated-orcid":false,"given":"Helmut","family":"Popper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"Suppl 1","key":"1790_CR1","first-page":"141","volume":"9","author":"H Yoshifuji","year":"2015","unstructured":"Yoshifuji H. Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies. Clin Med Insights Circ Respir Pulm Med. 2015;9(Suppl 1):141\u20136.","journal-title":"Clin Med Insights Circ Respir Pulm Med"},{"key":"1790_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/OARRR.S231195","volume":"12","author":"FM Alenzi","year":"2020","unstructured":"Alenzi FM. Myositis Specific Autoantibodies: A Clinical Perspective. Open Access Rheumatol. 2020;12:9\u201314.","journal-title":"Open Access Rheumatol"},{"key":"1790_CR3","doi-asserted-by":"publisher","first-page":"1286973","DOI":"10.3389\/fimmu.2024.1286973","volume":"15","author":"L Wang","year":"2024","unstructured":"Wang L, Lv C, You H, Xu L, Yuan F, Li J, Wu M, Zhou S, Da Z, Qian J, et al. Rapidly progressive interstitial lung disease risk prediction in anti-MDA5 positive dermatomyositis: the CROSS model. Front Immunol. 2024;15:1286973.","journal-title":"Front Immunol"},{"issue":"2","key":"1790_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12016-020-08822-5","volume":"60","author":"W Wu","year":"2021","unstructured":"Wu W, Guo L, Fu Y, Wang K, Zhang D, Xu W, Chen Z, Ye S. Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis. Clin Rev Allergy Immunol. 2021;60(2):293\u2013304.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"1790_CR5","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1212\/WNL.0000000000009727","volume":"95","author":"Y Allenbach","year":"2020","unstructured":"Allenbach Y, Uzunhan Y, Toquet S, Leroux G, Gallay L, Marquet A, Meyer A, Guillaud C, Limal N, Gagnadoux F, et al. Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 cases. Neurology. 2020;95(1):e70\u20138.","journal-title":"Neurology"},{"issue":"1","key":"1790_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41927-025-00455-5","volume":"9","author":"SK Koyoda","year":"2025","unstructured":"Koyoda SK, Ezzy F, Wahezi D, Kumthekar A, Xie X, Tagoe CE, Ayesha B. Antimelanoma differentiation-associated gene 5 (anti-MDA5) antibody-positive dermatomyositis: clinical features and outcomes in a racially diverse patient cohort. BMC Rheumatol. 2025;9(1):5.","journal-title":"BMC Rheumatol"},{"issue":"1","key":"1790_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13075-023-03243-z","volume":"26","author":"Y Qiu","year":"2024","unstructured":"Qiu Y, Feng X, Liu C, Shi Y, Xu L, You H, Wang L, Lv C, Wang F, Tan W. Proteomic profiling identifies SPP1 associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis. Arthritis Res Ther. 2024;26(1):9.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"1790_CR8","first-page":"269","volume":"42","author":"L Yang","year":"2024","unstructured":"Yang L, Zhang P, Yang Q, Zhang C, Guan W, Liu S. Clinical features of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with macrophage activation syndrome. Clin Exp Rheumatol. 2024;42(2):269\u201376.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"1790_CR9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.55563\/clinexprheumatol\/df2oc3","volume":"40","author":"Q Yang","year":"2022","unstructured":"Yang Q, Lyu K, Li J, Zhang P, Guan W, Zhang L, Han L, Liu S, Li T. Anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis exhibit three clinical phenotypes with different prognoses. Clin Exp Rheumatol. 2022;40(2):304\u20138.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"1790_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/rheumatology\/ket279","volume":"53","author":"P Venalis","year":"2014","unstructured":"Venalis P, Lundberg IE. Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy. Rheumatology (Oxford). 2014;53(3):397\u2013405.","journal-title":"Rheumatology (Oxford)"},{"key":"1790_CR11","doi-asserted-by":"publisher","first-page":"732298","DOI":"10.3389\/fimmu.2021.732298","volume":"12","author":"M Rentzsch","year":"2021","unstructured":"Rentzsch M, Wawrzinek R, Zelle-Rieser C, Strandt H, Bellmann L, Fuchsberger FF, Schulze J, Busmann J, Rademacher J, Sigl S, et al. Specific Protein Antigen Delivery to Human Langerhans Cells in Intact Skin. Front Immunol. 2021;12:732298.","journal-title":"Front Immunol"},{"issue":"1","key":"1790_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/1523-1747.ep12521102","volume":"75","author":"I Green","year":"1980","unstructured":"Green I, Stingl G, Shevach EM, Katz SI. Antigen presentation and allogeneic stimulation by Langerhans cells. J Invest Dermatol. 1980;75(1):44\u20135.","journal-title":"J Invest Dermatol"},{"issue":"2 Pt 1","key":"1790_CR13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0190-9622(91)70186-6","volume":"25","author":"G Hausmann","year":"1991","unstructured":"Hausmann G, Herrero C, Cid MC, Casademont J, Lecha M, Mascar\u00f3 JM. Immunopathologic study of skin lesions in dermatomyositis. J Am Acad Dermatol. 1991;25(2 Pt 1):225\u201330.","journal-title":"J Am Acad Dermatol"},{"key":"1790_CR14","doi-asserted-by":"publisher","first-page":"773352","DOI":"10.3389\/fimmu.2021.773352","volume":"12","author":"A Nombel","year":"2021","unstructured":"Nombel A, Fabien N, Coutant F. Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies. Front Immunol. 2021;12:773352.","journal-title":"Front Immunol"},{"issue":"5","key":"1790_CR15","doi-asserted-by":"publisher","first-page":"667","DOI":"10.5858\/134.5.667","volume":"134","author":"S Mukhopadhyay","year":"2010","unstructured":"Mukhopadhyay S, Gal AA. Granulomatous lung disease: an approach to the differential diagnosis. Arch Pathol Lab Med. 2010;134(5):667\u201390.","journal-title":"Arch Pathol Lab Med"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-026-01790-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-026-01790-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-026-01790-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:55:05Z","timestamp":1781484905000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13000-026-01790-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1790"],"URL":"https:\/\/doi.org\/10.1186\/s13000-026-01790-y","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"23 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study adhere to the Declaration of Helsinki. Patients gave their consent, that the tissues can be used for scientific investigation. As no personal data from patients have been used and all cases were anonymized, no informed consent from patients was necessary. The study was approved by the Ethics Committee of the Medical University Graz (EK 24\u2013135 ex 11\/12).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}